Zhang Zhongfu, Wang Yadong, Zhao Qing, Li Ganhong, Zhao Xingqi, Li Jun, Li Xianxin
Department of Urological Surgery, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong 518036, P.R. China.
Department of Urology, Zunyi Medical College Fifth Affiliated Hospital, Zhuhai, Guangdong 519100, P.R. China.
Oncol Lett. 2014 Nov;8(5):2325-2327. doi: 10.3892/ol.2014.2493. Epub 2014 Sep 1.
Adenosquamous carcinoma (ASC) and sarcomatoid carcinoma (SC) of the prostate are rare, but highly aggressive tumors. The occurrence of mixed carcinomas in the prostate is even more rarely reported. The present study reports the case of a 62-year-old male who was diagnosed with prostatic adenocarcinoma accompanied by multiple bone metastases, as shown by a needle biopsy and skeletal computed tomography scan. The patient was treated with hormonal therapy, but thereafter, specimens from a transurethral resection of the prostate (TURP) were found to be composed of three histologically distinct elements: ASC, SC and adenocarcinoma. The level of p53 was evaluated by immunohistochemistry in detail, and it was found that this was significantly increased in the TURP samples compared with the needle biopsy samples. The abnormal level of p53 was likely associated with the prognosis of the patient; the patient succumbed to prostate carcinoma two months after the confirmation of the diagnosis.
前列腺腺鳞癌(ASC)和肉瘤样癌(SC)较为罕见,但具有高度侵袭性。前列腺混合癌的发生则报道得更为罕见。本研究报告了一例62岁男性患者,经穿刺活检和骨骼计算机断层扫描显示,其被诊断为伴有多处骨转移的前列腺腺癌。该患者接受了激素治疗,但之后经尿道前列腺切除术(TURP)的标本发现由三种组织学上不同的成分组成:ASC、SC和腺癌。通过免疫组织化学详细评估了p53水平,发现与穿刺活检样本相比,TURP样本中的p53水平显著升高。p53水平异常可能与患者的预后相关;确诊两个月后,该患者死于前列腺癌。